Experienced and collaborative team, with diverse and complementary backgrounds. The investment team have deep scientific and commercial expertise
Roy Bartel-Taverner, MD
Analyst
Michelle Brandt
Executive Assistant
Felix Breyer, PhD
Associate
Laura Craig
Investor Relations Officer
Angela Ené
Interim Finance Director
Jade Fletcher
Financial Controller
Robert Lyne
CEO
Peregrine Moncreiffe
Chairman
Debra Barker, MD
Senior Independent Director
Isaac Kohlberg
Non-Executive Director
Maureen O’Connell
Andrew Smith